US 10072066
Methods and compositions for treatment of a beta thalessemia
granted A61KA61K2035/124A61K35/28
Quick answer
US patent 10072066 (Methods and compositions for treatment of a beta thalessemia) held by Sangamo Therapeutics, Inc. expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2035/124, A61K35/28, A61P, A61P7/00